On Wednesday February 21, Aphria posted on its social media accounts that their phase 3 expansion was complete. The next step before the greenhouse can have marijuana plants move in is receiving Health Canada approval. A timely phase 3 expansion is key to meeting EBITDA expectations over the next year – Phase 3 is expected to more than triple Aphria’s production capacity (excluding their Broken Coast acquisition) from 9,000 KG/year to 30,000 KG/year. This is well above retail and wholesale medical demand for Aphria’s marijuana products, which are selling at a 5,000 KG/year run rate. In other words this expansion is […]